Hazard ratios for time to infection by mean glucose (relative to a reference value of mean glucose of 100 mg/dL) stratified by HSCT type for each time interval and adjusted for the interaction between HSCT type and glucose. (A) Pre-HSCT mean glucose. (B) Days 0 to 30 mean glucose. (C) Days 0 to 100 mean glucose. (D) Days −14 to +100 mean glucose. The association between mean glucose at any interval and time to infection was modified by HSCT type. Patients who underwent allogeneic HSCT continued to demonstrate that increased mean glucose was associated with shorter time to infection, whereas patients who underwent autologous HSCT demonstrated slightly longer time to infection with increased mean glucose.